Lipella Pharmaceuticals Inc. Common Stock (LIPO) is a biotechnology company listed on NASDAQ.
Latest reported LIPO revenue for 2024-12-31 was $536.4K. Net income was -$5.0M. Revenue was up 19.3% from 2023-12-31 to 2024-12-31. LIPO currently screens at market cap $254.1K.
Use this LIPO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the LIPO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the LIPO SEC filings page. Lician reads the product cache first so this HTML stays unique to Lipella Pharmaceuticals Inc. Common Stock even when a live quote feed is slow.
Latest cached year on this hub. Full LIPO income, balance, and cash tables.